Do PPIs increase hip fracture risk?Gastroenterology group updates its position on proton pump inhibitor therapy and the risk of hip fracture. Orencia now available in subcutaneous formulationRheumatoid arthritis drug now available in two formats. Lupus patients often fail to get Pap tests Screening falls short despite higher risk for cervical dysplasia Brain ‘awry’ in fibromyalgia Scans help explain why these patients don’t respond well to opioids Proximity to uranium plant linked with lupus Studies suggest estrogen-like effects could help explain the finding Biologics linked with reduced mortality in rheumatoid arthritis Those on biologics also spent fewer days in hospital Health Canada approves Cymbalta for the management of osteoarthritis knee pain Test reveals arthritis risk Research Highlights: Cephalosporin use in penicillin allergy Review evaluates literature pertaining to cross-reactivity between penicillins and cephalosporins. Clinical Notes: Canadian RA guidelines address drug safety concerns New recommendations focus on the safety of traditional and biologic disease-modifying antirheumatic drugs First Previous 14 15 16 17 18 Next Last
